[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Duloxetine Market Analysis by Grade, Forms & Application, Trends, Share & Challenges Analysis & Industry Forecast (2018-2023)

September 2018 | 106 pages | ID: G97C4359D95EN
SPER Market Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
REPORT DESCRIPTION

This report represents the global and regional analysis of Duloxetine in terms of Dosage, Strength, API, application Wise segmentation, market size & market growth (in terms of value & volume) trends including forecasting upto 5 years. All the region wise segmentation of buyer supplier is described properly. The report focuses on the top continent Wise (North America, Europe, Japan, China and other regions (India, Southeast Asia, Central & South America, and Middle East & Africa) manufacturer & buyers also.

Duloxetine Introduction

“Duloxetine” is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) antidepressants generally used for treating depression, anxiety disorder, and pain. Duloxetine mainly affects neurotransmitters, the chemicals that nerves within the brain make and release in order to communicate with one another. Neurotransmitters either travel across the space between nerves or attach to receptors on the surface of nearby nerves or they attach to receptors on the surface of the nerves that produced them, to be taken up by the nerve and released again (a process referred to as re-uptake). Duloxetine targets major depressive disorders. It is manufactured & marketed by Eli Lilly & Company.

REPORT HIGHLIGHTS
  • Provide manufacturing capacity, consumption, current & past status & also the forecasting upto 2022.
  • Provide complete overview including type, application & forecast region.
  • Provide complete analysis of API & formulation including brand names, strength & market overview.
  • Provide focused analysis of key manufacturer with their production volume, market share & also help to identify market competition landscape with SWOT analysis.
  • Historical, current and projected market size in terms of volume and value.
  • Analyze the global & regional potential market, advantages, risk & opportunity.
  • Identify significant trends and factors driving or inhibiting the market growth.
  • In-depth coverage of complete market in terms of supplier, buyer, price, trend, growth & forecasting.
The report covers Applications;
  • Major Depressive Disorder (MDD)
  • Generalized Anxiety Disorder (GAD)
  • Diabetic Peripheral Neuropathic Pain
  • Fibromyalgia
  • Chronic Musculoskeletal Pain
The report covers exhaustive analysis on;
  • Market Segments
  • Market Dynamics
  • Brands In Market
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies Involved
  • Forecasting
  • Technology
The report includes Regional analysis on;
  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Rest of Latin America)
  • Europe (Germany, Italy, France, U.K, Spain & Rest of Europe)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Middle East and Africa (GCC Countries, South Africa, North Africa & Rest of MEA)
Top Players in Duloxetine industry
  • Eli Lilly And Company
  • Shanghai Zhongxi Pharmaceutical Co., Ltd
  • Lupin Pharma
  • Zydus Pharma USA
  • Dr. Reddy’s Labs
  • Actavis Elizabeth
  • Aurobindo Pharma
  • Teva Pharms USA
  • Breckenridge Pharm
Key Questions answered by report
  • What was the market size trend of 2014-2016?
  • What will be the market size trend of next 4-5 years?
  • What are the most common brands in terms of volume?
  • How much brands available for Duloxetine?
  • Who are the key players of Duloxetine API?
  • What are the major application industries & emerging industries?
  • Who are the key vendors present in the market?
  • How the future opportunities & market drivers will affect the market dynamics & ongoing trends?
  • Which one segment from global coverage will be lucrative & will grow?
  • What are the main market opportunities and threats faced by the vendors?
  • What are the strategies are following by the existing market players?
CHAPTER 1 RESEARCH METHODOLOGY

CHAPTER 2 REPORT DESCRIPTION

CHAPTER 3 DULOXETINE EXECUTIVE SUMMARY

CHAPTER 4 DULOXETINE BASIC HIGHLIGHTS

4.1. Product Overview
4.2. CAS No & Molecular Weight
4.3. Innovator Details
4.4. Priority & Patent Expiry
4.5. Molecular Formula
4.6. Market Status

CHAPTER 5 GLOBAL DULOXETINE PHYSICAL FORMS, GRADES & APPLICATION INDUSTRY

5.1. Duloxetine Forms (Anhydrous or Monohydrate)
5.2. Duloxetine Grades Description
5.3. Duloxetine Route of Administration
5.4. Duloxetine Synonym
5.5. Duloxetine Applications
  5.5.1. Major Depressive Disorder (MDD)
  5.5.2. Generalized Anxiety Disorder (GAD)
  5.5.3. Diabetic Peripheral Neuropathic Pain
  5.5.4. Fibromyalgia
  5.5.5. Chronic Musculoskeletal Pain

CHAPTER 6 DULOXETINE MANUFACTURING PROCESS WITH UPSTREAM & DOWNSTREAM

6.1. Duloxetine Manufacturing Process Routes & Flow Chart
6.2. Duloxetine Upstream & Downstream Products

CHAPTER 7 DULOXETINE BRAND LIST & MECHANISM OF ACTION

7.1. Duloxetine All Global Brands
7.2. Duloxetine Dosage & Their Strengths
7.3. Duloxetine Mechanism of Action

CHAPTER 8 DULOXETINE (FORMULATION) REGION WISE MARKET OVERVIEW

8.1. Duloxetine Market Overview In Asia-Pacific (China, India, South Korea & Rest of Asia Pacific Available)
8.2. Duloxetine Market Overview In Europe (Germany, Russia, United Kingdom & Rest of Europe Available)
8.3. Duloxetine Market Overview In North America (Canada, US & Rest of North America Available)
8.4. Duloxetine Market Overview In South America (Brazil, Argentina & Rest of South America Available)
8.5. Duloxetine Market Overview In Middle East & Africa (GCC Countries, South Africa, North Africa & Rest of MEA Available)

CHAPTER 9 DULOXETINE (API) REGION WISE MARKET OVERVIEW

9.1. Duloxetine Market Overview In Asia-Pacific (China, India, South Korea & Rest of Asia Pacific Available)
9.2. Duloxetine Market Overview In Europe (Germany, Russia, United Kingdom & Rest of Europe Available)
9.3. Duloxetine Market Overview In North America (Canada, US & Rest of North America Available)
9.4. Duloxetine Market Overview In South America (Brazil, Argentina & Rest of South America Available)
9.5. Duloxetine Market Overview In Middle East & Africa (GCC Countries, South Africa, North Africa & Rest of MEA Available)

CHAPTER 10 DULOXETINE (API & FORMULATION) CONTINENT & COUNTRY WISE MANUFACTURERS, MANUFACTURING VOLUME & CONTACT OVERVIEW

10.1. Duloxetine Continent Wise Manufacturers
10.2. Duloxetine Continent Wise Manufacturing Volume
10.3. Duloxetine Country Wise Manufacturers
10.4. Duloxetine Country Wise Manufacturing Volume
10.5. Duloxetine Manufacturers Contact Overview

CHAPTER 11 DULOXETINE GLOBAL PRICE TREND ANALYSIS OF LAST 3 YEARS

11.1. Duloxetine Global Price Trend Analysis
11.2. Duloxetine Country Wise Price Trend Analysis

CHAPTER 12 DULOXETINE INTERNATIONAL MARKET OVERVIEW

12.1. Global Demand/ Supply & Global Prices
12.2. Major Destinations Involved In Trade
12.3. Major Manufacturers (Capacities & Prices)

CHAPTER 13 DULOXETINE (FORMULATION) GLOBAL MARKET SIZE & MARKET GROWTH FORECASTING (2017-2022) ANALYSIS

13.1. Duloxetine Global Market Size (Past & Future Forecasting)
13.2. Duloxetine Global Market Growth (Past & Future Forecasting)
13.3. Duloxetine Continent Wise Market Size (Past & Future Forecasting)
13.4. Duloxetine Continent Wise Market Growth (Past & Future Forecasting)

CHAPTER 14 DULOXETINE (FORMULATION) CUSTOMER WISE CONSUMPTION, QUANTITY & CONTACT OVERVIEW

14.1. Duloxetine Global Consumers
14.2. Duloxetine Global Consumers As Per Consumption Quantity
14.3. Duloxetine Continent Wise Consumer
14.4. Duloxetine Continent Wise Consumer As Per Consumption Quantity
14.5. Duloxetine Country Wise Consumer
14.6. Duloxetine Country Wise Consumer As Per Consumption Quantity
14.7. Duloxetine Consumers Contact Overview

CHAPTER 15 DULOXETINE CONTINENT WISE EXPORT/ IMPORT ANALYSIS

15.1. Duloxetine Continent Wise Import Analysis
15.2. Duloxetine Continent Wise Export Analysis
15.3. Duloxetine Country Wise Import Analysis
15.4. Duloxetine Country Wise Export Analysis

CHAPTER 16 DULOXETINE WORLDWIDE SWOT ANALYSIS

16.1. Duloxetine Strength Analysis
16.2. Duloxetine Weakness Analysis
16.3. Duloxetine Opportunity Analysis
16.4. Duloxetine Threat Analysis

CHAPTER 17 DULOXETINE REPORT BASED BUSINESS RECOMMENDATION


More Publications